COMPUESTOS DE PPAR
LA PRESENTE INVENCION SE REFIERE A ACTIVADORES DE PPAR ALFA, COMPOSICIONES FARMACEUTICAS QUE CONTIENEN TALES COMPUESTOS Y SU USO PARA ELEVAR CIERTOS NIVELES DE LIPIDOS EN PLASMA, INCLUYENDO EL COLESTEROL ASOCIADO A LIPOPROTEINAS DE ALTA DENSIDAD Y PARA REDUCIR OTROS NIVELES DE LIPIDOS EN PLASMA COMO...
Gespeichert in:
Hauptverfasser: | , |
---|---|
Format: | Patent |
Sprache: | spa |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | DAVID AUSTEN PERRY CHERYL MYERS HAYWARD |
description | LA PRESENTE INVENCION SE REFIERE A ACTIVADORES DE PPAR ALFA, COMPOSICIONES FARMACEUTICAS QUE CONTIENEN TALES COMPUESTOS Y SU USO PARA ELEVAR CIERTOS NIVELES DE LIPIDOS EN PLASMA, INCLUYENDO EL COLESTEROL ASOCIADO A LIPOPROTEINAS DE ALTA DENSIDAD Y PARA REDUCIR OTROS NIVELES DE LIPIDOS EN PLASMA COMO EL COLESTEROL ASOCIADO A LDL. POR LO TANTO ESTOS COMPUESTOS SON UTILES EN ENFERMEDADES TALES COMO ATEROSCLEROSIS Y ENFERMEDADES CARDIOVASCULARES EN MAMIFEROS, INCLUYENDO SERES HUMANOS.
PPAR alpha activators, pharmaceutical compositions containing such compounds and the use of such compounds to elevate certain plasma lipid levels, including high density lipoprotein-cholesterol and to lower certain other plasma lipid levels, such as LDL-cholesterol and triglycerides and accordingly to treat diseases which are exacerbated by low levels of HDL cholesterol and/or high levels of LDL-cholesterol and triglycerides, such as atherosclerosis and cardiovascular diseases, in mammals, including humans. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_GT200200028A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>GT200200028A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_GT200200028A3</originalsourceid><addsrcrecordid>eNrjZBBy9vcNCHUNDvEPVnBxVQgIcAziYWBNS8wpTuWF0twMim6uIc4euqkF-fGpxQWJyal5qSXx7iFGBgZAZGBk4WhMjBoAO8cd9w</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>COMPUESTOS DE PPAR</title><source>esp@cenet</source><creator>DAVID AUSTEN PERRY ; CHERYL MYERS HAYWARD</creator><creatorcontrib>DAVID AUSTEN PERRY ; CHERYL MYERS HAYWARD</creatorcontrib><description>LA PRESENTE INVENCION SE REFIERE A ACTIVADORES DE PPAR ALFA, COMPOSICIONES FARMACEUTICAS QUE CONTIENEN TALES COMPUESTOS Y SU USO PARA ELEVAR CIERTOS NIVELES DE LIPIDOS EN PLASMA, INCLUYENDO EL COLESTEROL ASOCIADO A LIPOPROTEINAS DE ALTA DENSIDAD Y PARA REDUCIR OTROS NIVELES DE LIPIDOS EN PLASMA COMO EL COLESTEROL ASOCIADO A LDL. POR LO TANTO ESTOS COMPUESTOS SON UTILES EN ENFERMEDADES TALES COMO ATEROSCLEROSIS Y ENFERMEDADES CARDIOVASCULARES EN MAMIFEROS, INCLUYENDO SERES HUMANOS.
PPAR alpha activators, pharmaceutical compositions containing such compounds and the use of such compounds to elevate certain plasma lipid levels, including high density lipoprotein-cholesterol and to lower certain other plasma lipid levels, such as LDL-cholesterol and triglycerides and accordingly to treat diseases which are exacerbated by low levels of HDL cholesterol and/or high levels of LDL-cholesterol and triglycerides, such as atherosclerosis and cardiovascular diseases, in mammals, including humans.</description><edition>6</edition><language>spa</language><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS ; ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM ; CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2002</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20021001&DB=EPODOC&CC=GT&NR=200200028A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20021001&DB=EPODOC&CC=GT&NR=200200028A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>DAVID AUSTEN PERRY</creatorcontrib><creatorcontrib>CHERYL MYERS HAYWARD</creatorcontrib><title>COMPUESTOS DE PPAR</title><description>LA PRESENTE INVENCION SE REFIERE A ACTIVADORES DE PPAR ALFA, COMPOSICIONES FARMACEUTICAS QUE CONTIENEN TALES COMPUESTOS Y SU USO PARA ELEVAR CIERTOS NIVELES DE LIPIDOS EN PLASMA, INCLUYENDO EL COLESTEROL ASOCIADO A LIPOPROTEINAS DE ALTA DENSIDAD Y PARA REDUCIR OTROS NIVELES DE LIPIDOS EN PLASMA COMO EL COLESTEROL ASOCIADO A LDL. POR LO TANTO ESTOS COMPUESTOS SON UTILES EN ENFERMEDADES TALES COMO ATEROSCLEROSIS Y ENFERMEDADES CARDIOVASCULARES EN MAMIFEROS, INCLUYENDO SERES HUMANOS.
PPAR alpha activators, pharmaceutical compositions containing such compounds and the use of such compounds to elevate certain plasma lipid levels, including high density lipoprotein-cholesterol and to lower certain other plasma lipid levels, such as LDL-cholesterol and triglycerides and accordingly to treat diseases which are exacerbated by low levels of HDL cholesterol and/or high levels of LDL-cholesterol and triglycerides, such as atherosclerosis and cardiovascular diseases, in mammals, including humans.</description><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS</subject><subject>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM</subject><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2002</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZBBy9vcNCHUNDvEPVnBxVQgIcAziYWBNS8wpTuWF0twMim6uIc4euqkF-fGpxQWJyal5qSXx7iFGBgZAZGBk4WhMjBoAO8cd9w</recordid><startdate>20021001</startdate><enddate>20021001</enddate><creator>DAVID AUSTEN PERRY</creator><creator>CHERYL MYERS HAYWARD</creator><scope>EVB</scope></search><sort><creationdate>20021001</creationdate><title>COMPUESTOS DE PPAR</title><author>DAVID AUSTEN PERRY ; CHERYL MYERS HAYWARD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_GT200200028A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>spa</language><creationdate>2002</creationdate><topic>ACYCLIC OR CARBOCYCLIC COMPOUNDS</topic><topic>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM</topic><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>DAVID AUSTEN PERRY</creatorcontrib><creatorcontrib>CHERYL MYERS HAYWARD</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>DAVID AUSTEN PERRY</au><au>CHERYL MYERS HAYWARD</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>COMPUESTOS DE PPAR</title><date>2002-10-01</date><risdate>2002</risdate><abstract>LA PRESENTE INVENCION SE REFIERE A ACTIVADORES DE PPAR ALFA, COMPOSICIONES FARMACEUTICAS QUE CONTIENEN TALES COMPUESTOS Y SU USO PARA ELEVAR CIERTOS NIVELES DE LIPIDOS EN PLASMA, INCLUYENDO EL COLESTEROL ASOCIADO A LIPOPROTEINAS DE ALTA DENSIDAD Y PARA REDUCIR OTROS NIVELES DE LIPIDOS EN PLASMA COMO EL COLESTEROL ASOCIADO A LDL. POR LO TANTO ESTOS COMPUESTOS SON UTILES EN ENFERMEDADES TALES COMO ATEROSCLEROSIS Y ENFERMEDADES CARDIOVASCULARES EN MAMIFEROS, INCLUYENDO SERES HUMANOS.
PPAR alpha activators, pharmaceutical compositions containing such compounds and the use of such compounds to elevate certain plasma lipid levels, including high density lipoprotein-cholesterol and to lower certain other plasma lipid levels, such as LDL-cholesterol and triglycerides and accordingly to treat diseases which are exacerbated by low levels of HDL cholesterol and/or high levels of LDL-cholesterol and triglycerides, such as atherosclerosis and cardiovascular diseases, in mammals, including humans.</abstract><edition>6</edition><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | spa |
recordid | cdi_epo_espacenet_GT200200028A |
source | esp@cenet |
subjects | ACYCLIC OR CARBOCYCLIC COMPOUNDS ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | COMPUESTOS DE PPAR |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T21%3A38%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=DAVID%20AUSTEN%20PERRY&rft.date=2002-10-01&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EGT200200028A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |